As the Lipid Technology sector of Croda Pharma, Avanti is focused on developing innovative lipid-based products of unparalleled purity to address specific medical challenges that are not resolved by current technology or drug products. Over the past decade, we have concentrated on developing the lipid components used in Lipid Nanoparticle delivery technology to solve the stability and delivery issues associated with mRNA-based vaccines and therapeutics, as well as gene editing technology.